CytoReason

Presentation Time and Location
on 25th, during Rising Israeli Stars Session (from 15.40 to 16.15)
Company Website
www.cytoreason.com
Company Profile

CytoReason is a big-data analytics company specializing in immunotherapy using its proprietary Cell-Centered Model. The proprietary machine-learning engine enhances its performance with each new dataset introduced, leveraging hundreds of published and unpublished immunotherapy datasets. Its prior knowledge allows for ever-improving accuracy, translating high-resolution measurements to specific immune-cellular interactions that extend beyond the data provided by the customer and can be translated to valuable IP. CytoReason’s technology has yielded 2 pending patents, 7 scientific collaborations and 12 peer reviewed publications

Company Type
Other Sector
Immunology
Keywords

immuno-oncology

inflammatory diseases

inflammatory autoimmune 

big data

biomarker

Year Founded
2016
Pipeline Product 1: Name/Stage
proprietary Cell-Centered Model
Product 1: Description

Our technology integrates different genomic and proteomic measurements with clinical data and predicts cellular immunological pathways.

The proprietary machine-learning engine enhances its performance with each new dataset introduced, leveraging hundreds of published and unpublished immunotherapy trials. Its prior knowledge allows for ever-improving accuracy, translating high-resolution measurements to specific immune-cellular interactions. The system generates immune interaction networks that extend beyond the data provided by the customer.  

CytoReason is generating valuable IP and Know-How for biotech and pharmaceutical companies, universities and research institutions throughout their basic research, drug development, and clinical trials. 

Investment and Licensing (In/Out) Opportunity 1: Name
collaboration
Dr Orit Shaked
Dr Orit Shaked
BD 
Conference attendance
Biography

Experienced Vice President Of Business Development with a demonstrated history of working in the pharmaceuticals industry. Skilled in Medical Devices, Biotechnology, Fundraising, Biomedical Engineering, and Start-ups. Strong sales professional 

David Harel
President 
Conference attendance

Karmagenes SA

Presentation Time and Location
on 25th, during Rising European Stars Session (from 16.15 to 17.15)
Company Website
http://karmagenes.co
Company Profile
At Karmagenes, we do behavioral genetic and psychological analysis to improve people’s personal and professional life. Karmagenes SA is a Swiss-based startup and its scientific team has developed proprietary algorithms that a) provide an unbiased view of genetic potential through DNA-based personality test, b) assess current personality through KG5+ psychological tool and c) offer custom advice through in-house psychologist regarding career orientation, partnership and wellbeing.

Since more than 450mio people have a bad mental being affecting their capacity ‘’to work and to love’’, our next step is to apply our technology to a life coaching app combining psychological and genetic data analysis coupled with artificial intelligence. 

At your fingertip, you will have access to our existing network of coaches and specialists who can help you improve your overall wellbeing by understanding the real you.

Company Type
Other Sector
DTC Genetic Testing
Keywords

DNA, PSYCHOLOGY, NATURE, NURTURE, COACHING, BIOTECH, GENETIC TEST, ASSESSMENT, INNOVATION, PERSONALISED, FUTURE

Kyriakos Kokkoris PhD
Kyriakos Kokkoris PhD
CEO 
Conference attendance
Biography

https://www.linkedin.com/in/kyriakoskokkoris/

Oxyprem

Presentation Time and Location
on 25th, during Rising European Stars Session (from 16.15 to 17.15)
Company Website
www.oxyprem.com
Alexander Nitsch
Co-Founder 
Conference attendance
Dr. Stefan Kleiser
Co-Founder 
Conference attendance

Scailyte AG

Presentation Time and Location
on 25th, during Rising European Stars Session (from 16.15 to 17.15)
Company Profile

Scailyte AG is an innovative Swiss-based company developing artificial intelligence (AI) technology for clinical research and diagnostics. We are offering a unique solution for the discovery of novel biomarkers for ultra-sensitive and early diagnosis of complex diseases such as cancer.

Company Type
Keywords

artificial intelligence, diagnostics, single-cell, medtech, biomarker, big data

Dr. Peter Nestorov
Founder & CEO 
Conference attendance
Biography

https://www.linkedin.com/in/peternestorov/
2014: PhD Genetics
2008: MSc Biochemistry